Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

ru-486

ru-486

3 results

Filter Results By

Filter Applied. Clear All

Latest Posts

April 10, 2024 New Study: Abortion Increases Risk of Cardiovascular Diseases New Study: Abortion Increases Risk of Cardiovascular Diseases April 2, 2024 Abortion Reporting: Florida (2023) Abortion Reporting: Florida (2023) March 25, 2024 Filed: CLI Amicus Brief in Idaho’s Moyle v. United States EMTALA Case Filed: CLI Amicus Brief in Idaho’s Moyle v. United States EMTALA Case
Reset All Filters
3 results
ru-486

Utah Considers Ban on Telemedicine Abortions

A bill prohibiting doctors from issuing prescriptions for drugs to cause abortion via remote video or telephone conference passed Utah’s House Public Utilities, Energy, and Technology Standing Committee on January 30.

Tim Bradley
February 21, 2017
ClosePlease login
featured-image
ru-486

Bicameral Congressional Letter Demands Transparency from FDA

Yesterday 75 members of Congress, led by Rep. Chris Smith of New Jersey and Sen. James Lankford of Oklahoma, sent a letter to the Commissioner of the Food and Drug Administration demanding answers to questions about the FDA’s surprise approval of relaxed protocols for the distribution of the abortion-inducing drug regimen known as Mifeprex.

ru-486

Medication Abortion: FDA Guidelines and Personal Experience

Last week, the Food and Drug Administration (FDA) changed the regulations for RU-486, the “abortion pill,” allowing its use up to 70 days into pregnancy, three weeks past the previous guidelines. On the same day, Abby Johnson’s The Walls Are Talking: Former Abortion Clinic Workers Tell Their Stories, was officially released. One chapter in particular stood out as especially timely in regards to the news: “Medication Abortion.”

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image